Healthcare

By

Bruce Kamich

 | May 31, 2016 | 2:58 PM EDT

Our quantitative service has upgraded the drug maker to a buy, but the technicals are not ready yet to join in.

By

Jim Cramer

 | May 31, 2016 | 1:37 PM EDT

Allergan and retailers are just a couple of examples.

By

Bruce Kamich

 | May 31, 2016 | 12:36 PM EDT

CELG needs to close above its April highs to kickstart a rally to around the $120 area.

By

Jim Cramer and Jack Mohr

 | May 31, 2016 | 11:30 AM EDT

We expect an upward revision in AGN's valuation multiple after the generics deal with Teva.

By

Bruce Kamich

 | May 31, 2016 | 11:25 AM EDT

We should go long ARIA on available weakness and risk below $6.50.

By

Tony Owusu

 | May 31, 2016 | 11:15 AM EDT

Allergan's stock may start to realize the potential already seen by several Real Money analysts and contributors.

By

Bret Jensen

 | May 31, 2016 | 10:00 AM EDT

The uptick in the small- and mid-cap space bodes well for future capital appreciation.

By

Timothy Collins

 | May 30, 2016 | 8:00 PM EDT

Bulls need a close over resistance at $236.

By

The Deal

 | May 28, 2016 | 2:00 PM EDT

Problems with mesh products and high leverage might scare away a potential buyer. 

By

Jim Collins

 | May 27, 2016 | 3:13 PM EDT

Timing is key in investing and EYES shares should pop if a rights offering proves successful for the cash-needy company.

Agribusiness Bunge (BG) showed some bullish option buying last week. The stock gained anot...
The Fed has been talkative lately about the 'strength' in the economy with a 2% rate of gr...
Market flat as we hit the noon hour. Oil tries once again to scale the $50 level. Biotec...
I would think he sees the boatload of cash coming to AGN if/when they close the TEVA deal ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.